This node is now inactive. (Merged with the New England Node to form the New England Consortium Node in 2010)
The Northern New England Node is a partnership between clinical addiction researchers at Harvard Medical School, other universities, and CTPs located in New England states -- Maine, Massachusetts, and Rhode Island. Together, the CTPs had over 48,000 admissions in 2001 for substance use disorders. The CTPs provide services to an ethnically diverse patient population with a variety of substance use disorders in rural, suburban, and urban locales. Special populations include individuals with comorbid psychiatric and medical illnesses, HIV-infected individuals, adolescents, pregnant women, and individuals involved with the criminal justice system.
- A Pilot Study of Osmotic-Release Methylphenidate (OROS-MPH) in Initiating and Maintaining Abstinence in Smokers with Attention Deficit Hyperactivity Disorder (ADHD) (CTN-0029)
- Randomized Controlled Trial of Osmotic-Release Methylphenidate (OROS-MPH) for Attention Deficit Hyperactivity Disorder in Adolescents with Substance Use Disorders (CTN-0028)
- Job-Seekers Training for Patients with Drug Dependence (CTN-0020)
- HIV and HCV Intervention in Drug Treatment Settings (CTN-0017)
- Patient Feedback: A Performance Improvement Study in Outpatient Addiction Treatment (CTN-0016)
- Buprenorphine/Naloxone (Bup/Nx) Facilitated Rehabilitation for Heroin Addicted Adolescents/Young Adults (CTN-0010)
As a result of scientific research, we know that addiction is a disease that affects both brain and behavior.
Formed with SAMHSA to reduce the gap between research results and treatment.